China’s Qiming Venture Partners Leads $37M In AI-Enabled Drug Discovery Start-Up
September 10, 2019 — 11:05 CST
This Data Is Locked!
This area is available only to Subscribers.
Insilico Medicine, a Hong Kong-based start-up specialized in next-generation artificial intelligence (AI) technology for drug discovery, has raised US$37 million in a series B round... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals